Clinical Trials Logo

Clinical Trial Summary

The study is designed to evaluate whether a florbetapir F 18 PET scan can impact clinical thinking when physicians are determining the likely cause of a subject's cognitive impairment.


Clinical Trial Description

n/a


Study Design

Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic


Related Conditions & MeSH terms


NCT number NCT01400425
Study type Interventional
Source Avid Radiopharmaceuticals
Contact
Status Completed
Phase Phase 3
Start date July 2011
Completion date July 2012